Evaluation and analysis of patients presenting neurodegenerative dementia with [11C]PiB positron emission tomography

Evaluation and analysis of patients presenting neurodegenerative dementia with [11C]PiB positron emission tomography - Evaluation and analysis of patients presenting neurodegenerative dementia with PiBPET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019363

Enrollment

160

Registered

2015-11-01

Start date

2016-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment(MCI),Alzheimer-type dementia(AD), Parkinson&#39

Interventions

We use [11C]PiB as amyloid beta radiotracer by administration intravenously.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: each disease;20 healthy control;40

Exclusion criteria

Exclusion criteria: Persons who several doctors think it is difficult participate the trial.

Design outcomes

Primary

Measure	Time frame
About each neurodegenerative disease,We compare ,[11C]PiB PET imaging with MRI and clnical syndrome.	—

Countries

Japan

Contacts

Public ContactTakamasa Yokoi

Nagoya University Department of Neurology

tayokoi@me.nagoya-ac.jp052-744-1975

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026